Rituximab as Rescue Therapy for Atezolizumab-Induced IgA Vasculitis

Cristina R Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M Herrmann · 2026

Read Rituximab as Rescue Therapy for Atezolizumab-Induced IgA Vasculitis by Cristina R Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M Herrmann (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13634387.txt.

Description

Cristina R Ortiz and three colleagues published this 2026 report of a kidney emergency triggered by a cancer immunotherapy drug. The drug, atezolizumab, frees the immune system to attack cancer, yet that freedom can turn immunity against healthy organs. A seventy-five-year-old man with advanced prostate cancer first developed a raised, purple rash after treatment. Kidney failure followed. A biopsy showed IgA vasculitis, an immune attack on small vessels, with aggressive inflammation inside the kidney's filters.

High-dose steroids brought only partial improvement, and body-wide inflammation persisted. The team then gave rituximab, which removes antibody-making B cells. Kidney function steadied, inflammatory markers normalized, and B cells vanished from his blood as intended. His cancer later advanced, yet the kidney gains held. The authors present the case, the first biopsy-proven one of its kind, as support for rituximab when steroids fall short.

Catalog record

CREATORCristina R Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M Herrmann
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13634387

Browse the full library · About the Tower of Babel